Livia Hegerova - Concepedia

Author

Livia Hegerova

Mayo Clinic in Arizona ORCID

Also Known As

Hegerova L, L Hegerova, L. Hegerova, Livia Hegerova, Livia T Hegerova, Livia T. Hegerova

Publications

976

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Arizona University of Minnesota Scripps Research Institute Mayo Clinic University of Minnesota Medical Center

About

Livia Hegerova is an author at Mayo Clinic in Arizona specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	189
2	Health Sciences	2	2	29
3	Blood Transplantation	2	2	29
4	Immunology	2	2	139
5	Emergency Medicine	1	1	18

Livia Hegerova

Publications

464

Citations

H-Index

Page 1

	Year	Citations
Metastasis to the Thyroid Gland Livia Hegerova, Marcio L. Griebeler, Jordan Reynolds, American Journal of Clinical Oncology	2013	156
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma Jaroslav Žák, Isaraphorn Pratumchai, Brett S. Marro, Science Lymphoid NeoplasiaHodgkin LymphomaCancer ImmunosurveillanceCheckpoint Inhibitor ImmunotherapyMedicine	2024	128
Efficient Generation and Cryopreservation of Cardiomyocytes Derived from Human Embryonic Stem Cells Chunhui Xu, Shailaja Police, Mohammad Hassanipour, Regenerative Medicine	2010	96
An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy Livia Hegerova, Alexis D. Leal, Darryl C. Grendahl, Supportive Care in Cancer Emetogenic ChemotherapyOncologyVenous DiseaseVenous ThrombosisMedicine	2014	32
Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation Livia Hegerova, Adam Bachan, Qing Cao, Biology of Blood and Marrow Transplantation ImmunohematologyCatheter-related ThrombosisHematological MalignancyThrombosisVenous Thrombosis	2018	18
Ruxolitinib Plus Nivolumab in Patients with R/R Hodgkin Lymphoma after Failure of Check-Point Inhibitors: Preliminary Report on Safety and Efficacy Veronika Bachanová, Livia Hegerova, Qing Cao, Blood	2021	13
Improving outcomes after allogeneic hematopoietic cell transplantation for Hodgkin lymphoma in the brentuximab vedotin era Livia Hegerova, Qing Cao, Aleksandr Lazaryan, Bone Marrow Transplantation Lymphoid NeoplasiaHodgkin LymphomaTransplantationMarrow TransplantationMedicine	2017	11
Disseminated Histoplasmosis: A Cause of Hemophagocytic Syndrome Livia Hegerova, Yi Lin Mayo Clinic Proceedings	2013	10

Page 1